CA2506331C - Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications - Google Patents

Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications Download PDF

Info

Publication number
CA2506331C
CA2506331C CA2506331A CA2506331A CA2506331C CA 2506331 C CA2506331 C CA 2506331C CA 2506331 A CA2506331 A CA 2506331A CA 2506331 A CA2506331 A CA 2506331A CA 2506331 C CA2506331 C CA 2506331C
Authority
CA
Canada
Prior art keywords
seq
protein
cells
polynucleotide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2506331A
Other languages
English (en)
French (fr)
Other versions
CA2506331A1 (fr
Inventor
Michel Seve
Alain Favier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Joseph Fourier Grenoble 1
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Universite Joseph Fourier Grenoble 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, Universite Joseph Fourier Grenoble 1 filed Critical Commissariat a lEnergie Atomique CEA
Publication of CA2506331A1 publication Critical patent/CA2506331A1/fr
Application granted granted Critical
Publication of CA2506331C publication Critical patent/CA2506331C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
CA2506331A 2002-11-18 2003-11-18 Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications Expired - Fee Related CA2506331C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0214374A FR2847263B1 (fr) 2002-11-18 2002-11-18 Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
FR02/14374 2002-11-18
PCT/FR2003/003413 WO2004046355A2 (fr) 2002-11-18 2003-11-18 Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications.

Publications (2)

Publication Number Publication Date
CA2506331A1 CA2506331A1 (fr) 2004-06-03
CA2506331C true CA2506331C (fr) 2015-02-17

Family

ID=32187667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2506331A Expired - Fee Related CA2506331C (fr) 2002-11-18 2003-11-18 Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications

Country Status (12)

Country Link
US (2) US7851164B2 (enExample)
EP (3) EP1563071B1 (enExample)
JP (2) JP4498144B2 (enExample)
CN (2) CN1738900B (enExample)
AT (2) ATE494376T1 (enExample)
AU (1) AU2003295025B2 (enExample)
CA (1) CA2506331C (enExample)
DE (2) DE60335676D1 (enExample)
DK (2) DK1925667T3 (enExample)
ES (3) ES2361639T3 (enExample)
FR (1) FR2847263B1 (enExample)
WO (1) WO2004046355A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus
US9023984B2 (en) 2006-12-29 2015-05-05 The Regents Of The University Of Colorado, A Body Corporate Diagnostic and therapeutic target for autoimmune diseases and uses thereof
WO2008096009A2 (en) * 2007-02-09 2008-08-14 Mellitech Polymorphism in the slc30a8 gene
JP5697995B2 (ja) * 2008-02-14 2015-04-08 ユニヴァルシテ リブレ デ ブリュッセル β細胞の画像化又は標的化において有用な、膵β細胞において優先的に発現される新たな細胞膜バイオマーカー
EP2334696A1 (en) * 2008-09-30 2011-06-22 Novo Nordisk A/S G6pc2-encoded beta cell surface tags
US20120070847A1 (en) 2008-11-07 2012-03-22 Jan Jensen Method For Detecting And Purifying Pancreatic Beta Cells
ES2585360T3 (es) * 2009-08-05 2016-10-05 Curna, Inc. Tratamiento de enfermedades relacionadas con un gen de la insulina (INS) por inhibición de la transcripción antisentido natural en un gen de la insulina (INS)
EP2537859A1 (en) 2011-06-23 2012-12-26 Université de Mons Molecules specifically binding pancreatic beta cells biomarkers
ES2684976T3 (es) 2012-04-13 2018-10-05 Diabetomics, Inc. Biomarcadores maternos para diabetes gestacional
CN104098675A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104098673A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
EP3123169B1 (en) * 2014-03-26 2022-05-04 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Flattop (fltp) is a novel biomarker for beta cell maturation
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520603D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
US11016085B2 (en) 2016-04-25 2021-05-25 The Johns Hopkins University ZNT8 assays for drug development and pharmaceutical compositions
CN106226526A (zh) * 2016-06-30 2016-12-14 深圳市亚辉龙生物科技股份有限公司 一种锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法
US11892457B2 (en) 2017-07-12 2024-02-06 The Johns Hopkins University Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis
CN113166241B (zh) * 2018-08-16 2025-02-25 约翰霍普金斯大学 人类znt8抗体
CN109734793B (zh) * 2019-03-14 2022-12-02 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种ZnT8重组蛋白及其制备方法和应用
WO2021030613A1 (en) * 2019-08-13 2021-02-18 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
US12366570B2 (en) 2019-10-01 2025-07-22 The Johns Hopkins University Cell-based ZNT8 assay
JP2024534047A (ja) 2021-08-20 2024-09-18 ザ・ジョンズ・ホプキンス・ユニバーシティ 膵臓ベータ細胞の特定のバイオマーカーに対する細胞表面抗体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NL9001083A (nl) 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
ZA97476B (en) * 1996-01-22 1998-07-21 Res Dev Foundation Novel methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells.
AU778155B2 (en) * 1999-12-13 2004-11-18 Scripps Research Institute, The Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors
WO2001094409A2 (en) * 2000-06-07 2001-12-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CA2421576A1 (en) * 2000-09-15 2002-03-28 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
US7459539B2 (en) * 2000-12-15 2008-12-02 Agensys, Inc. Antibody that binds zinc transporter protein 108P5H8

Also Published As

Publication number Publication date
ATE408689T1 (de) 2008-10-15
CN102250242A (zh) 2011-11-23
US20060246442A1 (en) 2006-11-02
DK1563071T3 (da) 2009-02-02
ES2314268T3 (es) 2009-03-16
WO2004046355A2 (fr) 2004-06-03
CA2506331A1 (fr) 2004-06-03
EP1563071A2 (fr) 2005-08-17
EP1925667B1 (fr) 2011-01-05
AU2003295025B2 (en) 2008-09-18
ES2361639T3 (es) 2011-06-20
DE60323664D1 (de) 2008-10-30
JP2010150262A (ja) 2010-07-08
EP2239272B1 (fr) 2014-01-01
FR2847263B1 (fr) 2006-01-13
CN1738900A (zh) 2006-02-22
JP2006506084A (ja) 2006-02-23
US9568482B2 (en) 2017-02-14
FR2847263A1 (fr) 2004-05-21
ES2454592T3 (es) 2014-04-11
WO2004046355A3 (fr) 2004-09-30
US7851164B2 (en) 2010-12-14
DK1925667T3 (da) 2011-04-26
EP2239272A2 (fr) 2010-10-13
AU2003295025A1 (en) 2004-06-15
ATE494376T1 (de) 2011-01-15
EP1563071B1 (fr) 2008-09-17
JP4498144B2 (ja) 2010-07-07
DE60335676D1 (de) 2011-02-17
CN1738900B (zh) 2011-07-06
EP2239272A3 (fr) 2010-12-08
EP1925667A1 (fr) 2008-05-28
US20110027807A1 (en) 2011-02-03
JP5202550B2 (ja) 2013-06-05

Similar Documents

Publication Publication Date Title
CA2506331C (fr) Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications
Bassi et al. Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc–
US11845963B2 (en) HSD17B13 variants and uses thereof
Gautier-Courteille et al. The olfactory adenylyl cyclase III is expressed in rat germ cells during spermiogenesis
Liu et al. URB expression in human bone marrow stromal cells and during mouse development
FR2759701A1 (fr) Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
JP4086492B2 (ja) 糖尿病治療用医薬
EP1453861A2 (fr) Polynucleotide et proteine impliques dans la synaptogenese, variants de ceux-ci et leurs applications therapeutiques et diagnostiques
KR101460737B1 (ko) Ｍｇ53-ｕｂｅ2ｈ 상호작용을 이용한 제2형 당뇨 치료제의 스크리닝 방법
CA2401438C (fr) Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
CA2405124A1 (fr) Gene codant pour l'erbin et utilisations diagnostiques et therapeutiques
CA2518761A1 (fr) Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal
EP1317527A2 (fr) Genes cellulaires impliques dans l'oncogenese, les produits de ces genes et leurs applications diagnostiques et therapeutiques
FR2795074A1 (fr) Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
WO2003087153A1 (fr) Proteine knox-25 en doigt de zinc de type kruppel de souris et son utilisation
WO2002036630A2 (fr) Proteine recepteur de la renine et/ou de la prorenine, acide nucleique codant pour ce recepteur et leurs applications
FR2848573A1 (fr) Compositions et methodes pour la detection et le traitement de pathologies neurodegeneratives
EP1409675A1 (fr) Gene implique dans la regulation de l'apoptose
WO2003087372A2 (fr) Facteur de croissance derive d’hepatome et son utilisation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181119